SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Vascular and Endovascular Surgery
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rubin, R. N.
Right arrow Articles by Rubin, R. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rubin, R. N.
Right arrow Articles by Rubin, R. N.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Systemic Coagulation Effects Associated with Intra-Arterial Infusions of Low Doses of Streptokinase for Peripheral Arterial Occlusions

Ronald N. Rubin, M.D., F.A.C.A.

From the Department of Internal Medicine, Thrombosis Research Center, Temple University Hospital and School of Medicine, Philadelphia, Pennsylvania

Anthony J. Comerota, M.D., F.A.C.A.

From the Department of Surgery, Thrombosis Research Center, Temple University Hospital and School of Medicine, Philadelphia, Pennsylvania

Renate Soulen, M.D.

From the Department of Radiology, Temple University Hospital and School of Medicine, Philadelphia, Pennsylvania

Ronald N. Rubin, M.D., F.A. C.A.

3401 N. Broad Street Philadelphia, PA 19140

Streptokinase (SK) arterial infusion has become an increasingly used method in the therapy of peripheral arterial occlusive disease. Dosage regimens and durations of therapy are extremely variable. The degree of alteration in the coagulation system has not been adequately addressed. Such alterations might have profound significance regarding patient selection, nature of contraindica tions and degree of toxicity. We have systematically studied the effects of very low doses of SK given intra-arterially in peripheral arterial occlusive disease states. Our detailed studies demonstrate a profound systemic effect on the clot ting mechanism and function in such patients with marked lowering of fibrino gen, depletion of plasminogen and overall hypocoagulability. The effects of these findings on the clinical aspects of this therapeutic technique are discussed.

Vascular and Endovascular Surgery, Vol. 20, No. 3, 175-180 (1986)
DOI: 10.1177/153857448602000306
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement